X
Pharma body agrees five-year deal to boost NHS innovation
https://pharmaphorum.com/news/abpi-agrees-five-year-deal-to-boost-nhs-innovation/
Innovation
Bayer and MD Anderson collaborate on novel targeted cancer treatments
Bayer and the University of Texas MD Anderson Cancer Center have signed a five-year collaboration agreement to accelerate the development of novel targeted treatments for cancer.
Disruptive Innovations US
Latest thinking for 21st century drug development
